Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

Clinical trial NCT05520749 · COMPLETED

Trial details

NCT number: NCT05520749
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS
Status: COMPLETED
Study type: OBSERVATIONAL

Myeloid Dysplasia

Start date: 2022-01-01
Primary completion: 2022-12-31
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.